ROVAMYCINE 1.5 MILLIONS D'UNITES INTERNATIONALES, lyophilizate for parenteral use bottle
Active ingredients: Spiramycin, SPIRAMYCINE (ADIPATE DE)
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Lyophilizate for parenteral usebottleintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- ROVAMYCINE 1,5 MILLIONS D'UNITES INTERNATIONALES, lyophilisat pour usage parentéral
- Pharmaceutical form
- lyophilisat pour usage parentéral
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 1500000 UI
- Marketing authorisation holder
- TAMRISA ACCESS (FRANCE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1988
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65952065CIP75559545CIP133400955595458Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPIRAMYCINE (ADIPATE DE)lyophilisat | — | SA |
| SPIRAMYCINElyophilisat | 1 500 000 UI · un flacon de lyophilisat | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.